Antibody-Drug Conjugates for Breast Cancer: How They Work and What to Expect

[@yerbba]

Get your Yerbba Report Here: www.yerbba.com/ Take control of your breast cancer treatment with personalized insights.

[@BeateSchierle]

Thank you, Dr. Griggs! This came perfectly for me today...I am going to have my first chemo of T-DM1 on Tuesday and am quite anxious. Please keep your fingers crossed everyone! Beate from Germany

[@jeangresty3831]

All my best wishes to you Beate! You will be in my prayers.

[@BeateSchierle]

@@jeangresty3831 Thank you! This is so kind...

[@cynthiayee5116]

I HAVE COMPLETED MY CHEMO JUST 3 MONTHS AGO ! WISHING YOU ALL THE BEST ..AND STAY STRONG.

[@BeateSchierle]

@@cynthiayee5116 Thank you Cynthia! Hope you are doing well! ♥

[@yerbba]

We're all rooting for you here, and we're sending positive thoughts your way for a smooth treatment process. Thank you for watching!

[@naththomas9946]

Thank you, Dr. Griggs, for promoting and supporting breast cancer (health).

[@yerbba]

Thank you for your kind words!

[@HL-qv3yd]

Hi Dr Griggs thank you for your help, can you also make a video about what's near future promising drugs to be approve er pr positive her2 negative breast cancers? Is there any medication coming for this type please? Thank you❤

[@yerbba]

Thanks for the question. We've been hesitant to have videos about newer therapies because our videos live on our channel indefinitely. This means that anything that is out of date can cause problems for our subscribers. For example, if a drug looks promising in initial studies and then is found to be ineffective or harmful, we could confuse people and give them information that they find harder to trust. In general, the treatments for ER-positive, HER2-negative breast cancer are far ahead of treatment for other types of breast cancer in part because this is the most common type of breast cancer. The data are mature and rich for this type of breast cancer although, of course, we're always trying to do better.

[@HL-qv3yd]

Thank you ❤❤❤❤

[@Aasha271]

Very very informative videos u r making Alao can you make ki67 role in reaccurance tnbc many thanks

[@yerbba]

In people with triple-negative breast cancer (TNBC), the ki67 level does not play a major role in either treatment or outcomes. The test is more helpful in distinguishing between higher and lower risk of ER-positive and/or PR-positive breast cancer.

[@Sacredly_sarah]

I saw something on my pathology report that says best blockers: D2, D5. What are those?

[@yerbba]

These are markers that are being tested in animal studies to see if drugs that can block these might improve outcomes, first in mice, and perhaps down the road in people.

[@kevanhubbard9673]

The only one of those antibody drugs I've heard of is Mogamulizumab,a bit of a month full!, and it's used to treat the rare T Cell Lymphomas called Mycosis Fungoides and Sezary Syndrome and probably other related T Cell Lymphomas too like PCTL NOS .

[@yerbba]

Thank you for sharing the advances in other diseases.